<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">58020</article-id><article-id pub-id-type="doi">10.7554/eLife.58020</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Cell Biology</subject></subj-group><subj-group subj-group-type="heading"><subject>Chromosomes and Gene Expression</subject></subj-group></article-categories><title-group><article-title>The RIF1-Long splice variant promotes G1 phase 53BP1 nuclear bodies to protect against replication stress</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-184521"><name><surname>Watts</surname><given-names>Lotte P</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-106321"><name><surname>Natsume</surname><given-names>Toyoaki</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3544-4491</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-154844"><name><surname>Saito</surname><given-names>Yuichiro</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-184522"><name><surname>Garzon</surname><given-names>Javier</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-212853"><name><surname>Dong</surname><given-names>Qianqian</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-212855"><name><surname>Boteva</surname><given-names>Lora</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-212856"><name><surname>Gilbert</surname><given-names>Nick</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="other" rid="par-6"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-95909"><name><surname>Kanemaki</surname><given-names>Masato T</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7657-1649</contrib-id><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="other" rid="par-5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-184523"><name><surname>Hiraga</surname><given-names>Shin-ichiro</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-106575"><name><surname>Donaldson</surname><given-names>Anne D</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7842-8136</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">Institute of Medical Sciences</institution>, <institution>University of Aberdeen Institute of Medical Sciences</institution>, <addr-line><named-content content-type="city">Aberdeen</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff2"><institution content-type="dept">Division of Molecular Cell Engineering</institution>, <institution>National Institute of Genetics</institution>, <addr-line><named-content content-type="city">Mishima</named-content></addr-line>, <country>Japan</country></aff><aff id="aff3"><institution content-type="dept">Chromosome Science</institution>, <institution>National Institute of Genetics</institution>, <addr-line><named-content content-type="city">Mishima</named-content></addr-line>, <country>Japan</country></aff><aff id="aff4"><institution content-type="dept">Institute of Genetics and Molecular Medicine</institution>, <institution>University of Edinburgh</institution>, <addr-line><named-content content-type="city">Edinburgh</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff5"><institution content-type="dept">Department of Chromosome Science,</institution>, <institution>National Institute of Genetics</institution>, <addr-line><named-content content-type="city">Mishima</named-content></addr-line>, <country>Japan</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-16916"><name><surname>Wellinger</surname><given-names>Raymund J</given-names></name><role>Reviewing editor</role><aff><institution>Fac Medecine/Université de Sherbrooke</institution>, <country>Canada</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>a.d.donaldson@abdn.ac.uk</email> (AD);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>03</day><month>11</month><year>2020</year></pub-date><volume>9</volume><elocation-id>e58020</elocation-id><history><date date-type="received"><day>17</day><month>04</month><year>2020</year></date><date date-type="accepted"><day>02</day><month>11</month><year>2020</year></date></history><permissions><copyright-statement>© 2020, Watts et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Watts et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-58020-v1.pdf"/><abstract><p>Human cells lacking RIF1 are highly sensitive to replication inhibitors, but the reasons for this sensitivity have been enigmatic. Here we show that RIF1 must be present both during replication stress and in the ensuing recovery period to promote cell survival. Of two isoforms produced by alternative splicing, we find that RIF1-Long alone can protect cells against replication inhibition, but RIF1-Short is incapable of mediating protection. Consistent with this isoform-specific role, RIF1-Long is required to promote the formation of the 53BP1 nuclear bodies that protect unrepaired damage sites in the G1 phase following replication stress. Overall, our observations show that RIF1 is needed at several cell cycle stages after replication insult, with the RIF1-Long isoform playing a specific role during the ensuing G1 phase in damage site protection.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000289</institution-id><institution>Cancer Research UK</institution></institution-wrap></funding-source><award-id>C1445/A20596</award-id><principal-award-recipient><name><surname>Donaldson</surname><given-names>Anne D</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000289</institution-id><institution>Cancer Research UK</institution></institution-wrap></funding-source><award-id>C1445/A19059</award-id><principal-award-recipient><name><surname>Donaldson</surname><given-names>Anne D</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001691</institution-id><institution>Japan Society for the Promotion of Science</institution></institution-wrap></funding-source><award-id>17K15068</award-id><principal-award-recipient><name><surname>Kanemaki</surname><given-names>Masato T</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001691</institution-id><institution>Japan Society for the Promotion of Science</institution></institution-wrap></funding-source><award-id>18H02170</award-id><principal-award-recipient><name><surname>Kanemaki</surname><given-names>Masato T</given-names></name></principal-award-recipient></award-group><award-group id="par-5"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001691</institution-id><institution>Japan Society for the Promotion of Science</institution></institution-wrap></funding-source><award-id>18H04719</award-id><principal-award-recipient><name><surname>Kanemaki</surname><given-names>Masato T</given-names></name></principal-award-recipient></award-group><award-group id="par-6"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000265</institution-id><institution>Medical Research Council</institution></institution-wrap></funding-source><award-id>MC_UU_00007/13</award-id><principal-award-recipient><name><surname>Gilbert</surname><given-names>Nick</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files.</p></sec><supplementary-material><ext-link xlink:href="elife-58020-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>